1983Archives of OphthalmologyRequires access

Metabolic Acidosis From Acetazolamide Therapy

Elizabeth L. Gabay

Open publisher page 9 citations

Abstract

To the Editor. —The carbonic anhydrase inhibitor acetazolamide is widely used to lower intraocular pressure. It also produces a mild, nonanion gap metabolic acidosis by interfering with the resorption of bicarbonate in the

About this research paper

What this paper is about

To the Editor. —The carbonic anhydrase inhibitor acetazolamide is widely used to lower intraocular pressure. It also produces a mild, nonanion gap metabolic acidosis by interfering with the resorption of bicarbonate in the

Why it matters

OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To the Editor. —The carbonic anhydrase inhibitor acetazolamide is widely used to lower intraocular pressure. It also produces a mild, nonanion gap metabolic acidosis by interfering with the resorption of bicarbonate in the

Key concepts: Acetazolamide, Metabolic acidosis, Acidosis, Medicine, Diuretic, Anesthesia, Intensive care medicine, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Metabolic Acidosis From Acetazolamide Therapy — Research Paper | ScholarLens